Immuneering Corporation is developing novel small molecules for cyclical inhibition of MEK targets, but they are still in early development. Their first developmental project, IMM-1-104, has shown ...
In efforts to better understand how plant photosynthesis is regulated, scientists are studying how Rubisco activity responds to light. In a new meta-analysis study, a team from the Realizing Increased ...